Gritstone bio Inc (NASDAQ:GRTS)
| 11.47 Delayed Data As of Sep 17 |  -2.07 / -15.29%Today’s Change | 2.54 Today|||52-Week Range 35.20 | +191.12% Year-to-Date |
Latest GRTS News | Press Releases
| 3 Explosive Biotech Stocks That Could 10X in 10 Years Sep 16 / MotleyFool.com - Paid Partner Content | Gritstone bio Inc. (GRTS) is a Great Momentum Stock: Should You Buy? Sep 09 / Zacks.com - Paid Partner Content |
| 3 Monster Stocks in the Making to Buy Right Now Sep 12 / MotleyFool.com - Paid Partner Content |
Today’s Trading
| Previous close | 13.54 |
| Today’s open | 14.00 |
| Day’s range | 11.44 - 14.33 |
| Volume | 181,447 |
| Average volume (3 months) | 710,183 |
| Market cap | $567.2M |
Data as of 4:00pm ET, 09/17/2021
Growth & Valuation
| Earnings growth (last year) | +0.98% |
| Earnings growth (this year) | +54.39% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -7.51% |
| P/E ratio | NM |
| Price/Sales | 36.88 |
| Price/Book | 3.27 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| CLVSClovis Oncology Inc | +0.23 | +4.99% |
| PRQRProQR Therapeutics N... | +0.23 | +2.79% |
| KDNYChinook Therapeutics... | -0.06 | -0.48% |
| ---- |
Data as of 4:03pm ET, 09/17/2021
Financials
| Next reporting date | November 16, 2021 |
| EPS forecast (this quarter) | -$0.53 |
| Annual revenue (last year) | $4.0M |
| Annual profit (last year) | -$105.3M |
| Net profit margin | -2,608.72% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Emeryville, California |
Forecasts
